# Hypermarcas

Hypermarcas is an Asset Manager based in São Paulo, Brazil.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** São Paulo, Brazil
- **Region:** Latin America
- **Address:** São Paulo, SP, Brazil
- **Founded:** 2001
- **Assets under management:** Undisclosed
- **Website:** hypermarcas.com.br

## Regulatory record

- **Reports private funds:** No

## About

João Alves de Queiroz Filho founded Hypermarcas in 2001, building on the pharmaceutical distribution business his family had operated since the 1960s. The company went public in 2008 after an aggressive acquisition spree that stitched together dozens of Brazilian consumer-product brands. At its peak as a conglomerate, Hypermarcas owned more than 180 household-name products — from diapers and condoms to sweeteners and cough syrup — making it a uniquely recognizable portfolio in Brazilian retail. For most of the 2010s, Hypermarcas was a branded-consumer-goods conglomerate spanning pharmaceuticals, personal care, and food. In the pharma unit, key assets included the prescription brands Cimegripe and Engov as well as the over-the-counter analgesics Doril and Coristina D. The personal-care division owned Sante (hair care), Paixão (condoms), and Jontex (condoms). Food assets included the sweeteners Finn and Zero-Cal and the powdered-beverage brand Frisco. The strategy relied on acquiring under-managed regional brands, centralizing distribution, and buying national television advertising at scale. Starting in 2017, Hypermarcas began divesting its non-pharma assets in a multi-year portfolio simplification. The sweetener brands Finn and Zero-Cal were sold to a Chilean group. The condom business, including the Paixão and Jontex brands, was sold to the Malaysian firm Karex. The food division was dismantled through additional divestments. By 2020, Hypermarcas had concentrated almost entirely on the pharmaceutical segment, exiting the consumer-goods conglomerate model. The company is listed on the B3 stock exchange in São Paulo under the ticker HYPE3. The structural distinctiveness of Hypermarcas is its evolution from a classic Latin American family-conglomerate into a focused public pharmaceutical company — a rare path in a region where diversified holding structures typically persist across generations. The Alves de Queiroz family maintained significant control throughout the metamorphosis, orchestrating the buy-and-sell cycle across two decades without losing operational command.

## Sectors

- Consumer Goods

## People

- João Alves de Queiroz Filho — Founder and Chairman

## Questions

### How did Hypermarcas transition from a consumer conglomerate to a pharmaceutical company?

Between 2017 and 2020, Hypermarcas divested its personal-care and food divisions in a series of asset sales. The condom brands Paixão and Jontex were sold to Malaysia's Karex, while sweetener brands Finn and Zero-Cal were sold to Chilean buyers. The company exited all non-pharma segments to focus exclusively on prescription and over-the-counter pharmaceuticals.

### Who controls Hypermarcas?

João Alves de Queiroz Filho, the founder, has remained the controlling shareholder and Chairman throughout the company's public listing and its strategic transformation. The Alves de Queiroz family's pharmaceutical roots date to the 1960s, predating the Hypermarcas corporate entity by four decades.

### What were Hypermarcas's most significant brand acquisitions?

Between 2001 and 2015, Hypermarcas acquired over 20 companies. Significant pharmaceutical acquisitions included the Cimegripe and Engov lines from Boehringer Ingelheim's Brazilian subsidiary and the OTC brands Doril and Coristina D from Sanofi. In personal care, the Sante hair-care brand and the Paixão condom line were built through acquisitions of local manufacturers.

### Does Hypermarcas still operate in the consumer-goods space?

No. Following a multi-year divestiture program completed around 2020, Hypermarcas exited the food and personal-care segments entirely. The company now operates as a dedicated pharmaceutical business, holding a portfolio of prescription and over-the-counter drug brands distributed across Brazil.

## Related profiles

- [SL Green Realty](https://altss.com/profile/sl-green-realty-corp)
- [ATS Corp](https://altss.com/profile/ats-corp-ats)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/hypermarcas-sa

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology